• Twitter
  • Facebook

Terms & conditions  Cookie policy   Privacy policy

Copyright © Cancer52. All rights reserved.

Cancer52 is registered as a charity in England and Wales (1174569) and a company limited by guarantee in England and Wales (7994413)

19 Jun 2018

Cancer52, together with use MY data, has produced a briefing paper entitled National Data Opt-out and what it means to cancer patients.

The paper was produced for distribution on the Cancer52 and use MY data shared stand at the PHE Cancer Data and Outcomes Conference 2018

1 Apr 2017

As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer Outcomes:  A Strategy for England 2015-2020’ in its Cancer Strategy recommendations grid April .

23 Dec 2015

On 23rd December 2015, Cancer52 published its Briefing Paper on Access to Medicines and Treatments.

7 Dec 2015

briefing on the implementation of Achieving World Class Outcomes: A Strategy for England 2015-2020.

21 Feb 2014

On 21st February 2014, Cancer52 published its Briefing Paper "VBA: NICE do it their way".

20 Sep 2013

On 20th September 2013, Cancer52 published Briefing Papers on Value Based Pricing (VBP) and the Cancer Drugs Fund (CDF); alongside an introductory debate on the topic among leading experts from within the Cancer52 family.

Please reload

Please reload